Semaglutide Depot Phase I/IIa Study Evaluates Safety, PK, and Efficacy for Monthly T2DM Dosing
Safety, Tolerability and Efficacy of Semaglutide Depot in Subjects With Type-2 Diabetes Mellitus
Abstract
A Phase I/IIa dose escalation study evaluated the safety, tolerability, pharmacokinetics, and efficacy of Semaglutide Depot for once-monthly administration in adults with T2DM.